Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Semaglutide
Therapeutic Area : Endocrinology
Study Phase : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs
Details : HeroPatch (semaglutide) is a trandermal patch which delivers glucagon-like peptide-1 (GLP-1) receptor agonist indicated for type 2 diabetes.
Product Name : Undisclosed
Product Type : Peptide
Upfront Cash : Not Applicable
December 19, 2024
Lead Product(s) : Semaglutide
Therapeutic Area : Endocrinology
Highest Development Status : Preclinical
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable